Kalipada Pahan

Kalipada Pahan (born 19 February 1964, Midnapore)[Ref is a professor of Neurological Sciences, Biochemistry, and Pharmacology, holding the Floyd A. Davis, M.D., Endowed Chair in Neurology at Rush University Medical Center. He is also a research career scientist at the Department of Veterans Affairs, Jesse Brown VA Medical Center. An Indian American neuroscientist, Pahan focuses on translational research related to multiple sclerosis, Parkinson's disease, Alzheimer's disease, dementia, and Batten disease . Life Early Life in India: Dr. Pahan was born in 1964 at a remote Indian village (Muksudpur) in Midnapore, West Bengal, India. He received his early education in Muksudpur High School and Changrachak High School followed by bachelor’s in Chemistry from Midnapore College, a renowned autonomous college, which was then under the University of Calcutta.

Pursuit of Education and his journey to the USA: After completing his graduation, he moved to Kolkata to pursue a Masters’ degree in Biochemistry and then completed Ph.D. in Biochemistry with Departmental fellowship. In 1992, he came to Medical University of South Carolina (MUSC), Charleston, SC for pursuing his post-doctoral studies, where he rose to the rank of Assistant Professor in 1998. In 1999, he moved to the College of Dentistry in University of Nebraska Medical Center as an Assistant Professor of Biochemistry. He was promoted to Associate Professor of Biochemistry in 2002. In 2006, he moved to Rush University Medical Center as a Professor and Floyd. A. Davis, M.D., Endowed Chair of Neurology.

Research Career Professor Pahan is highly regarded for his contributions to research on statins, cholesterol-lowering medications. His initial investigations focused on the role of statins in suppressing inflammatory responses within microglia, astroglia, and macrophages[Ref . This discovery significantly influenced subsequent studies on statin drugs. Over the past 30 years, Professor Pahan has conducted pioneering research into the efficacy of statins for neuronal diseases. His laboratory later demonstrated that statins have potential neuroprotective effects and may enhance locomotor activity in Parkinson's disease by inhibiting activation of p21/Ras[ref . Statins, classified as HMG CoA reductase inhibitors, are recognized for their cholesterol-lowering properties. Professor Pahan's research further revealed that statins can exert HMG CoA reductase-independent actions[Ref}, supporting cognitive function via the PPAR-alpha-CREB pathway[Ref . Most recently, his research has characterized a novel interaction between lipid metabolism and memory, indicating that the lipid-regulating transcription factor PPAR-alpha modulates hippocampal memory formation via transcriptional regulation of CREB (Roy et al., 2013, Cell Reports 4: 724–737), providing a potential explanation for the observed association between increased abdominal fat and memory impairment.

His laboratory is also renowned for its research on cinnamon, where findings indicate that this widely used spice may offer benefits for various neurological disorders, including enhancing memory and learning in individuals with learning difficulties[Ref .

In 2021, his discovery on nasal drugs for Parkinson's disease was selected among the top three neuroscience discoveries in the world by Penn Neuro..

Most importantly, his laboratory findings on cinnamon, cinnamon metabolite sodium benzoate, gemfibrozil, low-dose aspirin, and physically-modified saline RNS60 have been confirmed in patients with different diseases by many clinical trials performed by several groups all over the world: Awards & Honors He has written many book chapters and published more than 200 articles in many peer-reviewed journals including Journal of Biological Chemistry, Journal of Immunology, Journal of Neuroscience, Cell Death and Differentiation, Proceedings of the National Academy of Sciences of the United States of America, Journal of Clinical Investigation, Science Signaling, Cell Reports, Cell Metabolism, Nature Communications, and Nature Chemical Biology. His research on aspirin was featured in Society for Neuroscience 2019 Hot Topic. He is the recipient of "D. H. Reinhardt Scholar" award from the University of Nebraska Medical Center (UNMC) College of Dentistry, the "Silver U" award from the UNMC Chancellor's council, and the outstanding teaching award from the UNMC College of Dentistry. He also received the Joseph Wybran, M.D., Award from the Society on Neuroimmune Pharmacology and the Zenith Fellows Award from the Alzheimer's Association.

1. Senior editor, Journal of Neuroimmune Pharmacology.

2. Senior editor, Neuroimmune Pharmacology and Therapeutics.

3. Editor-in-Chief, Journal of Multiple Sclerosis.

4. Permanent member, Clinical Neuroimmunology and Brain Tumors NIH study section.

5. Outstanding Teaching Award, University of Nebraska Medical Center College of Dentistry, 2000.

6. Outstanding Performance Award, University of Nebraska Medical Center College of Dentistry, 2000-2004.

7. Chancellor's Council Silver U Award, University of Nebraska Medical Center, 2004.

8. Reinhardt Research Scholar Award, University of Nebraska Medical Center College of Dentistry, 2005.

9. Floyd A. Davis, MD, Endowed Professor of Neurology, Rush University Medical Center, 2006.

10. Zenith Fellows Award, Alzheimer's Association, 2017.

11. Featured in Neuroscience Hot Topic, Society for Neuroscience, 2019.

12. Research Career Scientist Award, Veterans Affairs, 2019.

13. Joseph Wybran, MD, Award, Society for Neuroimmune Pharmacology, 2024.

14. BRAVE Award, Veterans Affairs, 2024.

Clinical evidence of his laboratory findings

Cinnamon metabolite sodium benzoate reduces amyloid plaques from Alzheimer's disease patients. Cinnamon is beneficial for patients with relapsing-remitting multiple sclerosis Cinnamon metabolite (Sodium Benzoate) improves memory and learning in patients with amnestic MCI Gemfibrozil in patients with Alzheimer's Disease Sodium Benzoate in patients with Later-Phase Dementia Low-dose Aspirin in Dementia patients Cinnamon in Rheumatoid Arthritis patients RNS60 (Physically-modified saline) in ALS patients Note: Reference for original characterization: Cinnamon for Cognitive Function (Systematic Review) RNS60 is beneficial in Stroke patients